Moreover, we postulate that the MEK/ERK-FAM83A feed-forward loop may be a novel therapeutic target in pancreatic cancer cells, including those that remain dependent on mutant RAS, as well as those that are independent of mutant RAS. The gene discussed is SACK1A; the disease is pancreatic neoplasm.